Search research articles
Contact Us
Filters
Showing results (31-40 of 60) with videos related to
Page
of 6
Sort By:
Environmental Science & Technology
|
February 19, 2025
Entropy Similarity-Driven Transformation Reaction Molecular Networking Reveals Transformation Pathways and Potential Risks of Emerging Contaminants in Wastewater: The Example of Sartans
Yuli Qian, Yunhao Ke, Liye Wang, et al.
Water Research
|
February 22, 2024
Unveiling intricate transformation pathways of emerging contaminants during wastewater treatment processes through simplified network analysis
Yuli Qian, Linchang Guan, Yunhao Ke, et al.
Clinical Pharmacology and Therapeutics
|
September 30, 2024
Extrapolation of Upadacitinib Efficacy in Juvenile Idiopathic Arthritis Leveraging Pharmacokinetics, Exposure-Response Models, and Real-World Patient Data
Yuli Qian, Louisa Schlachter, Doerthe Eckert, et al.
Medical Cannabis and Cannabinoids
|
December 5, 2022
The Influence of Cannabidiol on the Pharmacokinetics of Methylphenidate in Healthy Subjects
John S Markowitz, Ludmila De Faria, Qingchen Zhang, et al.
Current Pharmaceutical Design
|
July 30, 2013
Expression of histone acetyltransferase GCN5 and histone deacetylase 1 in the cultured mouse preimplantation embryos
Xiaozhen Liu, Dongmei Zhao, Yingming Zheng, et al.
Journal of Environmental Sciences (China)
|
February 27, 2022
Effects of DOM characteristics from real wastewater on the degradation of pharmaceutically active compounds by the UV/H<sub>2</sub>O<sub>2</sub> process
Yufei Shi, Jinju Geng, Xiang Li, et al.
Water Research
|
March 29, 2023
Revealing specific transformation pattern of sulfonamides during wastewater biological treatment processes by molecular networking nontarget screening
Gang Wu, Yuli Qian, Fan Fan, et al.
Clinical and Translational Science
|
December 17, 2024
Endogenous plasma riboflavin is not a viable BCRP biomarker in human
John P Savaryn, Ryota Kikuchi, Yuli Qian, et al.
Clinical and Translational Science
|
November 20, 2025
Optimization of Bottom-Up PBPK Model Development in SIMCYP via Retrospective Analysis of Clinical Human PK Data
Julia A Schulz Pauly, Alix F Leblanc, Ekram A Chowdhury, et al.
Clinical Pharmacology in Drug Development
|
February 27, 2024
Pharmacokinetics, Safety, and Tolerability of Cedirogant in Healthy Japanese and Chinese Adults
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda D'Cunha, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 60) with videos related to
Sort By:
Page
of 6
Environmental Science & Technology
|
February 19, 2025
Entropy Similarity-Driven Transformation Reaction Molecular Networking Reveals Transformation Pathways and Potential Risks of Emerging Contaminants in Wastewater: The Example of Sartans
Yuli Qian, Yunhao Ke, Liye Wang, et al.
Water Research
|
February 22, 2024
Unveiling intricate transformation pathways of emerging contaminants during wastewater treatment processes through simplified network analysis
Yuli Qian, Linchang Guan, Yunhao Ke, et al.
Clinical Pharmacology and Therapeutics
|
September 30, 2024
Extrapolation of Upadacitinib Efficacy in Juvenile Idiopathic Arthritis Leveraging Pharmacokinetics, Exposure-Response Models, and Real-World Patient Data
Yuli Qian, Louisa Schlachter, Doerthe Eckert, et al.
Medical Cannabis and Cannabinoids
|
December 5, 2022
The Influence of Cannabidiol on the Pharmacokinetics of Methylphenidate in Healthy Subjects
John S Markowitz, Ludmila De Faria, Qingchen Zhang, et al.
Current Pharmaceutical Design
|
July 30, 2013
Expression of histone acetyltransferase GCN5 and histone deacetylase 1 in the cultured mouse preimplantation embryos
Xiaozhen Liu, Dongmei Zhao, Yingming Zheng, et al.
Journal of Environmental Sciences (China)
|
February 27, 2022
Effects of DOM characteristics from real wastewater on the degradation of pharmaceutically active compounds by the UV/H<sub>2</sub>O<sub>2</sub> process
Yufei Shi, Jinju Geng, Xiang Li, et al.
Water Research
|
March 29, 2023
Revealing specific transformation pattern of sulfonamides during wastewater biological treatment processes by molecular networking nontarget screening
Gang Wu, Yuli Qian, Fan Fan, et al.
Clinical and Translational Science
|
December 17, 2024
Endogenous plasma riboflavin is not a viable BCRP biomarker in human
John P Savaryn, Ryota Kikuchi, Yuli Qian, et al.
Clinical and Translational Science
|
November 20, 2025
Optimization of Bottom-Up PBPK Model Development in SIMCYP via Retrospective Analysis of Clinical Human PK Data
Julia A Schulz Pauly, Alix F Leblanc, Ekram A Chowdhury, et al.
Clinical Pharmacology in Drug Development
|
February 27, 2024
Pharmacokinetics, Safety, and Tolerability of Cedirogant in Healthy Japanese and Chinese Adults
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda D'Cunha, et al.
Page
of 6